位置:首页 > 蛋白库 > TUT2_TRYBB
TUT2_TRYBB
ID   TUT2_TRYBB              Reviewed;         487 AA.
AC   Q86MV5;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   03-AUG-2022, entry version 57.
DE   RecName: Full=Terminal uridylyltransferase 2 {ECO:0000305};
DE            Short=TUTase 2 {ECO:0000305};
DE            EC=2.7.7.52 {ECO:0000269|PubMed:12820966, ECO:0000269|PubMed:16281058, ECO:0000269|PubMed:19465686, ECO:0000269|PubMed:20362585};
DE   AltName: Full=Mitochondrial protein 57 {ECO:0000303|PubMed:12649499};
DE            Short=TbMP57 {ECO:0000303|PubMed:12649499};
DE   AltName: Full=RNA editing 3' terminal uridylyltransferase 2 {ECO:0000303|PubMed:12820966};
DE            Short=RET2 {ECO:0000303|PubMed:12820966};
DE            Short=RNA editing TUTase 2 {ECO:0000303|PubMed:12820966};
DE   AltName: Full=RNA editing complex protein MP57 {ECO:0000303|PubMed:12820966};
DE   Flags: Precursor;
GN   Name=KRET2 {ECO:0000305}; Synonyms=MP57 {ECO:0000312|EMBL:AAO63567.1};
OS   Trypanosoma brucei brucei.
OC   Eukaryota; Discoba; Euglenozoa; Kinetoplastea; Metakinetoplastina;
OC   Trypanosomatida; Trypanosomatidae; Trypanosoma.
OX   NCBI_TaxID=5702;
RN   [1] {ECO:0000312|EMBL:AAO63567.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY,
RP   IDENTIFICATION IN THE RECC COMPLEX, INTERACTION WITH MP81, AND SUBCELLULAR
RP   LOCATION.
RC   STRAIN=IsTar I.7 {ECO:0000312|EMBL:AAO63567.1};
RX   PubMed=12820966; DOI=10.1016/s1097-2765(03)00185-0;
RA   Ernst N.L., Panicucci B., Igo R.P., Panigrahi A.K., Salavati R., Stuart K.;
RT   "TbMP57 is a 3' terminal uridylyl transferase (TUTase) of the Trypanosoma
RT   brucei editosome.";
RL   Mol. Cell 11:1525-1536(2003).
RN   [2] {ECO:0000312|EMBL:AAO63567.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], IDENTIFICATION IN THE RECC COMPLEX, AND
RP   SUBCELLULAR LOCATION.
RC   STRAIN=IsTar I.7 {ECO:0000312|EMBL:AAO63567.1};
RX   PubMed=12649499; DOI=10.1261/rna.2194603;
RA   Panigrahi A.K., Schnaufer A., Ernst N.L., Wang B., Carmean N., Salavati R.,
RA   Stuart K.;
RT   "Identification of novel components of Trypanosoma brucei editosomes.";
RL   RNA 9:484-492(2003).
RN   [3] {ECO:0000305}
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, IDENTIFICATION
RP   IN THE RECC COMPLEX, INTERACTION WITH MP81, AND SUBCELLULAR LOCATION.
RX   PubMed=19465686; DOI=10.1261/rna.1538809;
RA   Aphasizheva I., Ringpis G.E., Weng J., Gershon P.D., Lathrop R.H.,
RA   Aphasizhev R.;
RT   "Novel TUTase associates with an editosome-like complex in mitochondria of
RT   Trypanosoma brucei.";
RL   RNA 15:1322-1337(2009).
RN   [4] {ECO:0000305}
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, IDENTIFICATION
RP   IN THE RECC COMPLEX, INTERACTION WITH MP81, DOMAIN, AND DISRUPTION
RP   PHENOTYPE.
RX   PubMed=20362585; DOI=10.1016/j.jmb.2010.03.050;
RA   Ringpis G.E., Aphasizheva I., Wang X., Huang L., Lathrop R.H.,
RA   Hatfield G.W., Aphasizhev R.;
RT   "Mechanism of U insertion RNA editing in trypanosome mitochondria: the
RT   bimodal TUTase activity of the core complex.";
RL   J. Mol. Biol. 399:680-695(2010).
RN   [5] {ECO:0007744|PDB:2B4V, ECO:0007744|PDB:2B51, ECO:0007744|PDB:2B56}
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 20-487 OF MUTANT TRP-94; TRP-122
RP   AND TRP-207 IN COMPLEX WITH MAGNESIUM; MANGANESE AND UTP, FUNCTION,
RP   CATALYTIC ACTIVITY, COFACTOR, AND MUTAGENESIS OF TRP-94; TRP-122 AND
RP   TRP-207.
RX   PubMed=16281058; DOI=10.1038/sj.emboj.7600861;
RA   Deng J., Ernst N.L., Turley S., Stuart K.D., Hol W.G.;
RT   "Structural basis for UTP specificity of RNA editing TUTases from
RT   Trypanosoma brucei.";
RL   EMBO J. 24:4007-4017(2005).
CC   -!- FUNCTION: Terminal uridylyltransferase which, as part of the
CC       mitochondrial RNA editing core complex (RECC), is involved in the post-
CC       transcriptional editing of mitochondrial RNA, a process involving the
CC       addition and deletion of uridine (U) nucleotides in the pre-mRNA
CC       (PubMed:12820966, PubMed:19465686, PubMed:20362585). Specifically,
CC       catalyzes the addition of one U to single-stranded RNA with a
CC       preference for a 3'-terminal A or G and adds the number of Us specified
CC       by a guide RNA (gRNA) to precleaved double-stranded RNA editing
CC       substrates (PubMed:12820966, PubMed:19465686, PubMed:20362585,
CC       PubMed:16281058). Essential for the survival of the bloodstream form
CC       (PubMed:16281058). {ECO:0000269|PubMed:12820966,
CC       ECO:0000269|PubMed:16281058, ECO:0000269|PubMed:19465686,
CC       ECO:0000269|PubMed:20362585}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=RNA(n) + UTP = diphosphate + RNA(n)-3'-uridine ribonucleotide;
CC         Xref=Rhea:RHEA:14785, Rhea:RHEA-COMP:14527, Rhea:RHEA-COMP:17348,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:46398, ChEBI:CHEBI:140395,
CC         ChEBI:CHEBI:173116; EC=2.7.7.52;
CC         Evidence={ECO:0000269|PubMed:12820966, ECO:0000269|PubMed:16281058,
CC         ECO:0000269|PubMed:19465686, ECO:0000269|PubMed:20362585};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000305|PubMed:16281058};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000305|PubMed:16281058};
CC       Note=Binds 1 Mg(2+) or Mn(2+) per subunit.
CC       {ECO:0000269|PubMed:16281058};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.2 uM for UTP (with 6(U) single-stranded RNA as substrate)
CC         {ECO:0000269|PubMed:19465686};
CC         KM=3.4 uM for UTP (with double-stranded RNA as substrate)
CC         {ECO:0000269|PubMed:19465686};
CC         KM=2.5 uM for UTP (with RNA with no U in 3' position as substrate)
CC         {ECO:0000269|PubMed:19465686};
CC         KM=12.6 uM for UTP (with double-stranded RNA with one U in 3'
CC         position as substrate) {ECO:0000269|PubMed:19465686};
CC         Note=kcat is 0.0007 min(-1) with UTP and 6(U) single-stranded RNA as
CC         substrates (PubMed:19465686). kcat is 0.002 min(-1) with UTP and
CC         double-stranded RNA as substrates (PubMed:19465686). kcat is 0.02
CC         min(-1) with UTP and with RNA with no U in 3' position as substrates
CC         (PubMed:20362585). kcat is 0.2 min(-1) with UTP and double-stranded
CC         RNA with one U in 3' position as substrates (PubMed:20362585).
CC         {ECO:0000269|PubMed:19465686, ECO:0000269|PubMed:20362585};
CC   -!- SUBUNIT: Component of the mitochondrial RNA editing core complex
CC       (RECC), also known as the editosome complex (PubMed:12820966,
CC       PubMed:12649499, PubMed:19465686, PubMed:20362585). Interacts (via
CC       middle domain) with MP81; the interaction enhances MP57 catalytic
CC       activity and probably recruits MP57 to the RECC complex
CC       (PubMed:12820966, PubMed:20362585). {ECO:0000269|PubMed:12649499,
CC       ECO:0000269|PubMed:12820966, ECO:0000269|PubMed:19465686,
CC       ECO:0000269|PubMed:20362585}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:12649499,
CC       ECO:0000269|PubMed:12820966, ECO:0000269|PubMed:19465686}.
CC   -!- DISRUPTION PHENOTYPE: RNAi-mediated knockdown in the procyclic form
CC       causes growth arrest. {ECO:0000269|PubMed:20362585}.
CC   -!- SIMILARITY: Belongs to the DNA polymerase type-B-like family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY228173; AAO63567.1; -; Genomic_DNA.
DR   PDB; 2B4V; X-ray; 1.80 A; A=20-487.
DR   PDB; 2B51; X-ray; 2.05 A; A=20-487.
DR   PDB; 2B56; X-ray; 1.97 A; A=20-487.
DR   PDBsum; 2B4V; -.
DR   PDBsum; 2B51; -.
DR   PDBsum; 2B56; -.
DR   AlphaFoldDB; Q86MV5; -.
DR   SMR; Q86MV5; -.
DR   EvolutionaryTrace; Q86MV5; -.
DR   GO; GO:0031019; C:mitochondrial mRNA editing complex; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0050265; F:RNA uridylyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0071076; P:RNA 3' uridylation; IDA:UniProtKB.
DR   InterPro; IPR043519; NT_sf.
DR   InterPro; IPR002058; PAP_assoc.
DR   InterPro; IPR041060; Ret2_MD.
DR   Pfam; PF03828; PAP_assoc; 1.
DR   Pfam; PF18528; Ret2_MD; 1.
DR   SUPFAM; SSF81301; SSF81301; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Magnesium; Manganese; Metal-binding; Mitochondrion;
KW   mRNA processing; Nucleotide-binding; Nucleotidyltransferase; RNA-binding;
KW   Transferase; Transit peptide.
FT   TRANSIT         1..24
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255"
FT   CHAIN           25..487
FT                   /note="Terminal uridylyltransferase 2"
FT                   /id="PRO_0000449385"
FT   DOMAIN          366..425
FT                   /note="PAP-associated"
FT                   /evidence="ECO:0000255"
FT   REGION          151..264
FT                   /note="Middle domain (MD); important for the incorporation
FT                   into the RECC complex, for catalytic activity and possibly
FT                   RNA binding"
FT                   /evidence="ECO:0000269|PubMed:20362585"
FT   BINDING         85
FT                   /ligand="UTP"
FT                   /ligand_id="ChEBI:CHEBI:46398"
FT                   /evidence="ECO:0000269|PubMed:16281058,
FT                   ECO:0007744|PDB:2B51, ECO:0007744|PDB:2B56"
FT   BINDING         96..99
FT                   /ligand="UTP"
FT                   /ligand_id="ChEBI:CHEBI:46398"
FT                   /evidence="ECO:0000269|PubMed:16281058,
FT                   ECO:0007744|PDB:2B51, ECO:0007744|PDB:2B56"
FT   BINDING         97
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000269|PubMed:16281058"
FT   BINDING         99
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000269|PubMed:16281058"
FT   BINDING         210
FT                   /ligand="RNA"
FT                   /ligand_id="ChEBI:CHEBI:33697"
FT                   /evidence="ECO:0000250|UniProtKB:Q381M1"
FT   BINDING         277..278
FT                   /ligand="UTP"
FT                   /ligand_id="ChEBI:CHEBI:46398"
FT                   /evidence="ECO:0000269|PubMed:16281058,
FT                   ECO:0007744|PDB:2B51, ECO:0007744|PDB:2B56"
FT   BINDING         300
FT                   /ligand="UTP"
FT                   /ligand_id="ChEBI:CHEBI:46398"
FT                   /evidence="ECO:0000269|PubMed:16281058,
FT                   ECO:0007744|PDB:2B51, ECO:0007744|PDB:2B56"
FT   BINDING         304
FT                   /ligand="UTP"
FT                   /ligand_id="ChEBI:CHEBI:46398"
FT                   /evidence="ECO:0000269|PubMed:16281058,
FT                   ECO:0007744|PDB:2B51, ECO:0007744|PDB:2B56"
FT   BINDING         318..319
FT                   /ligand="UTP"
FT                   /ligand_id="ChEBI:CHEBI:46398"
FT                   /evidence="ECO:0000269|PubMed:16281058,
FT                   ECO:0007744|PDB:2B51, ECO:0007744|PDB:2B56"
FT   SITE            267
FT                   /note="Important for catalytic activity"
FT                   /evidence="ECO:0000305|PubMed:16281058"
FT   MUTAGEN         94
FT                   /note="W->R: No effect on catalytic activity; when
FT                   associated with R-122 and R-207."
FT                   /evidence="ECO:0000269|PubMed:16281058"
FT   MUTAGEN         122
FT                   /note="W->R: No effect on catalytic activity; when
FT                   associated with R-94 and R-207."
FT                   /evidence="ECO:0000269|PubMed:16281058"
FT   MUTAGEN         207
FT                   /note="W->R: No effect on catalytic activity; when
FT                   associated with R-94 and R-122."
FT                   /evidence="ECO:0000269|PubMed:16281058"
FT   HELIX           33..50
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   HELIX           54..74
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   STRAND          79..83
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   HELIX           85..89
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   STRAND          98..103
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   STRAND          105..108
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   HELIX           111..126
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   HELIX           131..134
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   STRAND          137..140
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   STRAND          142..145
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   STRAND          147..150
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   HELIX           155..163
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   HELIX           168..174
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   STRAND          176..183
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   HELIX           188..198
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   HELIX           200..202
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   STRAND          203..210
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   STRAND          212..223
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   HELIX           224..231
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   STRAND          237..240
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   HELIX           242..247
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   STRAND          248..253
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   HELIX           260..262
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   STRAND          266..270
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   HELIX           273..287
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   HELIX           292..304
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   TURN            307..309
FT                   /evidence="ECO:0007829|PDB:2B56"
FT   STRAND          311..314
FT                   /evidence="ECO:0007829|PDB:2B56"
FT   HELIX           318..331
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   HELIX           340..342
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   HELIX           346..348
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   HELIX           363..379
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   TURN            383..385
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   STRAND          386..388
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   STRAND          390..394
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   HELIX           398..401
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   HELIX           406..408
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   TURN            424..429
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   TURN            433..436
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   HELIX           439..458
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   TURN            461..463
FT                   /evidence="ECO:0007829|PDB:2B4V"
FT   HELIX           468..470
FT                   /evidence="ECO:0007829|PDB:2B4V"
SQ   SEQUENCE   487 AA;  56560 MW;  3B57EB6812D0619A CRC64;
     MLMHTAPWLH MRLSRLFRQS PLSLPSTKLN PSPDHYAVWG KAIMAENNRR VGPEHMFRTA
     IRAQQQLQGL ADKWTPDAKV YCCGSMVTYG QMEWGSDLDL ACMFDDPYPS HEVQAKRTDK
     LWTVIKRYVP HYLRNNLLGL TEARTPVVKL RFANDEKVAR ARYTPLSEEE DRKARTALLD
     VRNQCVGDND VEYIAEKMGR DNVEGIWVDR TTYGCRIAIQ CTSKEQMIEA IGFFPDGKIM
     TRGMREDYTR DVLDVRFVPE MFMYRWDISF VGYGVKNSYL IRHYLHNGPV AARHTAMAVK
     AWGKATNVGA GSGAMLTSYA VTVMFIYYLL VTRQVLWVDP WSLPHPAHLP RYPDFSPLYD
     CDPTELGRLL HGFFIFYAHH FDYEREVVSL NRNRRSYRSD IGWNFPQNKK GTFSYNFCIE
     DPYEDVGTGG LNLVRHLHPA KFQLVKQEFL RAAQCMERFL PTNAPEKSIL GVKRADLRHF
     ERDRDRE
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024